Arp Americas »

Cerevel Therapeutics Hldng I shares owned by Arp Americas

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Arp Americas from 13F filings

Historical chart of Arp Americas investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Arp Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Arp Americas

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.6M 109k 42.40

More positions owned by Arp Americas

Rpt Realty Sh Ben Int
Sovos Brands
Pioneer Natural Resources (PXD)
ImmunoGen
United States Steel Corporation (X)
Rayzebio
Cambridge Ban (CATC)
Karuna Therapeutics Ord
Cerevel Therapeutics Hldng I (CERE)
Albertsons Cos Common Stock (ACI)
Sp Plus (SP)
AmerisourceBergen (COR)
Eagle Bulk Shipping (EGLE)
Mosaic (MOS)
Baxter International (BAX)

View all positions for Arp Americas

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I